Copley Acquisition CORP 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
Copley Acquisition Corp. has entered into a definitive business combination agreement with Ignite Proteomics, LLC, a functional proteomics company focused on advancing precision oncology.
NYSE
Copley Acquisition Corp (COPL) has issued an unsecured convertible promissory note for up to $450,000 to its sponsor, Copley Acquisition Sponsors LLC, to fund working capital, consolidating a previous outstanding balance.
NYSE
Copley Acquisition Corp will allow separate trading of its Class A ordinary shares and warrants starting on or about June 2, 2025.
NYSE
Copley Acquisition Corp reports the resignation of its Chief Operating Officer, Tsz Chiu Guan, effective May 13, 2025.
NYSE
Copley Acquisition Corp successfully closed its initial public offering (IPO) on May 2, 2025, raising $172.5 million to pursue business combinations in the Asia Pacific and North American regions.
NYSE
Copley Acquisition Corp details the terms of its warrant agreement as part of its $172.5 million initial public offering.